netFormulary NHS
Southampton Joint Formulary
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Notes:

View the local COPD Inhaled Therapy Prescribing Guidance here

Chapter Links...
 Details...
03.04.02  Expand sub section  Allergen Immunotherapy
Bee/Wasp venom allergen extracts (Alutard SQ®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red

note Pharmalgen brand has been discontinued but may be supplied for selected patients when Alutard brand is not suitable.

 
Link  NICE TA246: Pharmalgen for bee and wasp venom allergy
   
BenralizumabBlack Triangle (Fasenra® )
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA565: Benralizumab for treating severe eosinophilic asthma
   
Grass and Tree Pollen Extract (Pollinex®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Restricted Item Specialist allergy clinics only

 
   
Grass pollen allergen extract (Grazax®)
(oral lyophilisate)
View adult BNF View SPC online View childrens BNF
Formulary
Red

Restricted Item Specialist allergy clinics only.

 
   
Lais® 1,000 AU
(sublingual tablets)
Formulary
Red

unlicensed Unlicensed

Restricted Item Specialist allergy clinics only. For use only when licensed alternatives are not suitable.

 
   
MepolizumabBlack Triangle (Nucala®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA431 : Mepolizumab for treating severe refractory eosinophilic asthma
   
Omalizumab (Xolair®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine

Occasionally used in primary care

 
Link  NICE TA278: Omalizumab for treating allergic asthma
Link  NICE TA339: Omalizumab for previously treated chronic spontaneous urticaria
   
Oralvac compact®
(oromucosal solution)
View adult BNF View childrens BNF
Formulary
Red

unlicensed unlicensed

Restricted Item Specialist allergy clinics only. For use only when licensed alternatives are not suitable.

 

 
   
Reslizumab
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
Link  NICE TA479: Reslizumab for treating severe eosinophillic asthma
   
 ....
 Non Formulary Items
Dupilumab Black Triangle  (Dupixent®)
(subcutaneous injection )

Non Formulary

Red Currently non-formulary for severe asthma (awaiting NICE TA guidance - due Jan 2021)

Red Currently non-formulary for treating chronic rhinosinusitis with nasal polyps. NICE TA648 - terminated appraisal.

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine

Traffic Light Status Information

Status Description

Green

Suitable for prescribing by all in both primary and secondary care.  

Amber Recommended

Specialist recommended but suitable for continuation in primary care.  

Amber Initiation

Specialist initiated but suitable for continuation in primary care.  

Amber SCG

Specialist initiated and for continuation in primary care under a locally approved shared care guideline.  

Red

Suitable for prescribing in specialist settings (secondary care) only.   

Red Specialist Centre

Secondary care medicines to be used under specialised commissioning arrangements only.  

Blue

For primary care, either via FP10 or supplied through specialist services. These products may be stocked by hospital pharmacies only for supply to primary care units/wards or for continuing supplies for patients admitted on therapy.  

Black

Not recommended for use.  

netFormulary